Thomas Evangelidis is a Senior Researcher in the Institute of Organic Chemistry and Biochemistry (IOCB) in Prague and CEITEC in Brno. He has 12 years of experience in novel method and software development for protein-ligand binding affinity prediction and NMR structure determination, for which he combines notions from Chemoinformatics, Machine Learning, and Quantum Chemistry. He is currently starting a spin-off company named "AIffinity", which will provide software and computational services for Molecular Binding Affinity prediction by AI and 4D NMR structure determination.
Thomas obtained his PhD in Computation Medicinal Chemistry & NMR from the Dept. of Pharmacy,
University of Athens, Greece & Central European Institute of Technology (CEITEC), Brno, Czech Republic. He continued in CEITEC for a 2-year post-doc on 4D-NMR protein structure determination. In 2018 he also joined IOCB, where he develops new methods for protein-ligand binding affinity prediction.
Monday 6th May
Target Identification; linking target and chemical properties to desired product pipeline.